Thermo Fisher Scientific (TMO) Short-term Investments (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Short-term Investments for 11 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• For the quarter ending Q1 2026, Short-term Investments fell 99.89% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (down 99.89% YoY), and the FY2025 full-year result was $253.0 million, down 83.79% from the prior year.
• Short-term Investments fell to $2.0 million in Q1 2026 per TMO's latest filing, from $253.0 million in the prior quarter.
• Across five years, Short-term Investments topped out at $2.0 billion in Q3 2024 and bottomed at $2.0 million in Q1 2026.
• Historically, Short-term Investments has averaged $1.3 billion across 4 years, with a median of $1.7 billion in 2024.
• The sharpest annual moves came in 2024 and 2026: Short-term Investments surged 51933.33% in 2024, then tumbled 99.89% in 2026.
• Over 4 years, Short-term Investments stood at $3.0 million in 2023, then soared by 51933.33% to $1.6 billion in 2024, then plunged by 83.79% to $253.0 million in 2025, then slumped by 99.21% to $2.0 million in 2026.
• According to Business Quant data, Short-term Investments over the past three periods registered $2.0 million, $253.0 million, and $1.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.